Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PubMed laboratory research record [PMID: 40834311] PubMed record related to this compound for laboratory literature review
Final pricing depends on program selection.Noom GLP-1Rx Plus Microdose Program involves medication (when appropriate), healthy diet, exercise and support
whether molecular endpoints were directly measured or inferred from general biology
This baseline serves two purposes
Retatrutide is a novel triple-acting peptide agonist that simultaneously targets three key hormonal pathways: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors
US$ 27.73
US$ 21.02
.png.jpg)
US$ 21.55
